Shinpoong Pharmaceutical Co Ltd (019175) — Cash Flow-to-Debt Ratio
Shinpoong Pharmaceutical Co Ltd (019175) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩3.42 Billion could theoretically repay 0% of its total liabilities (₩81.74 Billion) in one year. See free cash flow generation of Shinpoong Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shinpoong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Shinpoong Pharmaceutical Co Ltd across 12 annual periods. Also explore Shinpoong Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shinpoong Pharmaceutical Co Ltd (2014–2025)
Year-by-year debt coverage analysis for Shinpoong Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shinpoong Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | ₩17.25 Billion | ₩81.74 Billion | ▲ +217.0% |
| 2024 | -0.18x | ₩-15.15 Billion | ₩84.00 Billion | ▲ +42.3% |
| 2023 | -0.31x | ₩-24.81 Billion | ₩79.30 Billion | ▲ +63.6% |
| 2022 | -0.86x | ₩-26.44 Billion | ₩30.78 Billion | ▲ +54.0% |
| 2021 | -1.87x | ₩-71.03 Billion | ₩38.03 Billion | ▼ -1150.4% |
| 2020 | 0.18x | ₩20.06 Billion | ₩112.82 Billion | ▲ +57.1% |
| 2019 | 0.11x | ₩19.35 Billion | ₩170.99 Billion | ▼ -38.8% |
| 2018 | 0.18x | ₩32.05 Billion | ₩173.47 Billion | ▲ +219.6% |
| 2017 | 0.06x | ₩10.15 Billion | ₩175.50 Billion | ▼ -39.1% |
| 2016 | 0.09x | ₩18.96 Billion | ₩199.64 Billion | ▲ +107.3% |
| 2015 | 0.05x | ₩9.89 Billion | ₩215.87 Billion | ▲ +20820.1% |
| 2014 | 0.00x | ₩-48.16 Million | ₩217.78 Billion | — |